CYCLACEL PHARMACEUTICALS - CYCC 6 PERP (CYCCP) Stock Analyst Ratings
NASDAQ:CYCCP - Nasdaq - US23254L2079 - Currency: USD
ChartMill assigns a Buy % Consensus number of 43% to CYCCP. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 18.95. This target is 156.39% above the current price.
CYCCP was analyzed by 6 analysts. The buy percentage consensus is at 43. So analysts seem to be rather negative about CYCCP.
In the previous month the buy percentage consensus was at a similar level.
CYCCP was analyzed by 6 analysts. More opinions would make the average more meaningful.